We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
1.8p, and quickly would get my vote. Leave it to the Chinese - or any other buyer for that matter. The BOD here are useless and monetising a glorious product.
I'd take 1.5p to be out of the shuite show - 15 years of the same regurgitation of commentary. Concluding that this was a transitional period is utterly laughable. Whoever compared these results to a corner shop is correct. PXS is and always has been a shambles. I'm in it because it was my first ever investment and I'm too stubborn to get out, but I wouldn't touch a company like this as the modern version of myself.
The Chinese like the number 18nvery much. So IF please stick to this magic number of 18P .
I am glad you listened to me Krusty ;o).
Gixer's snippets are like white noise they mean nothing , it's just the money that matters and there is next to nothing when the directors take £250K approx out the Co annually.
If the Chinese get a positive result from SAMR then they might take out PXS prior to informing the market of their success. The Chinese are like that . In that case If we get 2p we will be lucky. I guess they might try that in about 6 months?
Whichever way you spin in gixer, this company still has the turnover of a corner shop. We've been told endlessly to expect "multiples" of current sales, but today no-one can tell shareholders when that might happen. We've been told that DSM will be selling loads of Fruitflow to support improved gut health, but they shifted hardly anything when selling a product proven to improve heart health so why should we think this will be any better? And they're now saying, as clearly as they've ever said, that another raise is imminent. If I were BYHEALTH I would be extremely concerned about the financial health of my UK partner in a business they have invested significantly in.
Thank goodness I decided not to add another half million yesterday.
Nice to see you are still around BB , always appreciate your posts.
In my last I did say it wouldn't be great . But I am just a doomsayer and not to be listened to. Carry on.
I don’t think that includes ff+ as we already have stock ,so maybe £145k on top
Correct Gixer, some only read what they want to see. Lets see full year results. Usual and new suspects putting there doom and gloom. Also raising is maybe not will have to
If sales are lower than wages, one has to ask when will they need funding to keep paying the wages?
£280k for first six months with another £155k in the pipeline. Its only September, we have another 6 months of the financial year to go. Think you are being a bit mean at £509k :)
Not sure you have those figures right.
Firstly, I would think that DSM would have made sure that their customers bought from them before they handed over, which would have a chilling effect for a while. Then, if turnover for the half year was 280k, the second half should deliver that and more. Having sales of 155k on the books at the start of the second half of the year, there's a good prospect that the second half will beat the first by some margin.
Setting up a despatch hub in Ireland is another cost, but, if it avoids tariffs (debatable), it could be self funding.
I've warned a few times that we shouldn't expect much from this report, only the full year to 24 will give a better guide.
I'm not happy that this view has been born out.
Terrible results. £354k in 9 months (74+280) with another £155k in the pipeline this year. So that will be about £509k (74+280+155) income in a full calendar year, with a good portion of that going to DSM.
That means BH order will potentially be multiple of not much.
This company just can't make a profit after 14 years of trading! At least it's clear that another fundraise is imminent.
Pretty underwhelming to be honest, with total revenue for FF ( from DSM and direct sales ) down, but at least we've got some flesh on the bones wrt sales of FF in H1 ( Apr to Sept ) for this FY for which we're still expected to be loss making.
I'd hoped our current cashflow would have been closer to break even than recent sales suggest. The need to fund raise is, as expected, still there but can't, I'm assuming, be very far away now.
BB
?
Ah ok. I wonder how the patent application is doing for that one. DSM has preferential access to the use this patent but i wonder how binding this partnership is remembering that it was based on DSM's study?
Gixer sorry I was referring to the gut microbiome which DSM are fastracking to market apparently ! Anyway let’s hope some answers are in the report tomorrow and as alfista has said don’t expect any news on funding as it has been a great tool to keep a cap on the sp for a year now , I might be a bit cynical but it has been frustrating .
Sphinx, the new function claim was only submitted on the 29th of August (one month ago) once SAMR finally officially released the "Implementation Rules for New Functions and Product Technology Evaluation of Health Foods" on 28th August.
The Technical Specifications for Testing and Evaluation of Health Food (2003 Version) was abolished in July 2018 so we can hardly blame PXS or By-Health for the delay. The good thing was By-Health were ready and waiting.
We know what we're waiting for.
The link with ByHealth, with their chief scientist having started his training with Provexis is the significant part of the story. All of the years developing Fruitflow, all of the added health function, but still they revert to the original one for Blue Cap approval. They have massive promotional capabilities, and have been preparing their PR offerings for ages. This is where the big numbers (and sp) is achievable, the extra revenues could unlock to door to proper promotion in other markets.
In that respect, we still have to wait. For the new trading pattern, we can hope to start gaining some insights.
I’m not expecting anything that will move the sp , more cut & paste and hopeful link ups with mysterious 3rd parties I expect . The “ New” function claim will be talked about even though it’s 15 months old now . Nothing happens with any pace at pxs I’m afraid . I hold in hope though!
Like many AIM CEO's Ian Ford has earned many millions by "running" a loss-making outfit. It really is a gravy train isn't it? 2009 to 2023 and yet to make a profit! It never really lived up to the potential and probably never will. Good product though.
Although there is no requirement to publish them I hope we get some (unofficial) figures for March to September.
Will we break even?
- no trade in jan, possibly part of Feb too
- loss due to lockdowns
- majority of customers transferred, not all.
We should see a some revenue increase, but not sure we’ll break even for year 22/23. Only 1 day until we find out.
Will it be 14 years in row 'No profit? OR being positive:Loss decreasing x